Answers are grounded in this paper and cite their sources.
Digital light processing (DLP) bioprinting, known for its speed and precision, has become a key tool in disease modeling and regenerative medicine. Yet, creating bioinks with optimal printability, bioactivity, and cell-supporting capacity remains a major challenge. Here, we introduce a novel dual-network collagen-based bioink, methyl acrylated collagen-dimethylphenylphosphonate (CMA-DPPA), which enables the fabrication of mechanically robust and highly printable cell-laden constructs through DLP 3D bioprinting. The CMA-DPPA hydrogel is synthesized by cross-linking collagen with DPPA, followed by photo-crosslinking with CMA; this dual-cross-linking approach markedly improves printing fidelity, mechanical strength, and enzymatic degradation resistance of the 3D-printed constructs. The CMA-DPPA hydrogel exhibits excellent biocompatibility, effectively promoting cell adhesion, proliferation, and migration. In a rat model of full-thickness skin defects, CMA-DPPA hydrogel facilitated organized collagen fiber deposition and accelerated epidermal regeneration, thereby expediting wound closure. CMA-DPPA bioink enables precise, robust scaffold fabrication, showing great promise for DLP-based tissue engineering and regenerative medicine.
No takes yet. Share an insight, caveat, or question.
Xiao et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: